Tumor-targeted Salmonella as a novel anticancer vector

Area of Science:

• Microbiology
• Oncology
• Gene Therapy

Background:

• Limited investigation exists on using bacteria as gene delivery vectors.
• Genetically engineered Salmonella possess properties suitable for a delivery vector, including tumor targeting and replication.

Purpose of the Study:

• To investigate the potential of genetically engineered Salmonella as a gene delivery vector for cancer therapy.
• To evaluate the efficacy of attenuated Salmonella strains in targeting tumors and delivering therapeutic genes.

Main Methods:

• Utilized attenuated, hyperinvasive auxotrophic Salmonella mutants for tumor targeting in melanoma-bearing mice.
• Constructed a plasmid expressing herpes simplex virus thymidine kinase (HSV TK) in Salmonella.
• Administered HSV TK-expressing Salmonella and ganciclovir to evaluate tumor suppression and survival rates.

Main Results:

• Attenuated Salmonella selectively replicated within tumors, achieving high tumor:liver ratios (250:1 to 9000:1).
• Salmonella inoculation suppressed tumor growth and doubled survival time in mice.
• HSV TK-expressing Salmonella combined with ganciclovir demonstrated dose-dependent tumor suppression and prolonged survival.

Conclusions:

• Attenuated Salmonella are effective gene delivery vectors with inherent antitumor activity.
• These bacteria can be engineered to deliver therapeutic proteins, like HSV TK, for enhanced cancer treatment.
• Genetically modified Salmonella offer a promising platform for in vivo cancer therapy.